Press Releases

Press Releases

Filters
Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results
Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer
Viatris Shareholders Re-elect All Nominated Directors and Approve All Voting Matters at Annual Meeting of Shareholders
Viatris to Participate in the Jefferies London Healthcare Conference
Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance
Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a Row
Rajiv Malik to Retire as President of Viatris Effective April 1, 2024
Displaying 1 - 10 of 89